Cancer treatment has seen revolutionary advancements when IL-2 immunotherapy emerged as the flagship in contemporary oncology research. Scientists and researchers have started developing new and improved versions of interleukin-2 (IL-2) to manage or cure different cancers and even autoimmune diseases, potentially. This protein, which the body makes naturally to modulate immune responses, became a building […]
Author Archives: Karol Nigam
Have you ever had challenges with inconsistent in vitro models in the testing of skin therapies or wound agents? Do you experience that primary keratinocytes quickly senesce, vary from donor to donor or become prohibitively expensive? In the meantime, there is pressure on reproducibility, and translational gaps between the bench and the bedside keep growing. […]
- 1
- 2



